VistaGen Therapeutics Reports Fiscal Year 2022 First Quarter Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. ABBV
4. META
5. FDX
6. IBM
7. MU
8. PFE
9. ACN
10. USO

Go back to VistaGen Therapeutics Reports Fiscal Year 2022 First Quarter Financial Results and Provides Corporate Update
(NASDAQ: VTGN) Delayed: 0.63 -0.01 (1.56%)
Previous Close $0.64    52 Week High $4.60 
Open $0.65    52 Week Low $2.81 
Day High $0.69    P/E N/A 
Day Low $0.61    EPS $0.00 
Volume 900,387